By Lívia Honório de Figueiredo
9 de August de 2017
Published ANVISA’s new rule relative to the prior consent for the granting of a patent for pharmaceutical products and processes
Valid since August 10 2017 – date of its publication on the Official Federal Gazette – this new rule confirms all the principals and procedures already stated on Normative Instruction Nº 01, from May 31 2017.
In case you need further information on this topic, our legal and technical teams are at your disposal in our offices of Rio de Janeiro, São Paulo and Porto Alegre, as well as the email: mail@kasznarleonardos.com
Last by Lívia Honório de Figueiredo
1 de July de 2026
INPI Ordinance No. 80/2026 and Second Medical Use Patents
INPI Ordinance No. 80/2026, published on June 30, 2026, in the Official Gazette No. 2895, revised Chapter 9 of the Guidelines for Examination … INPI Ordinance No. 80/2026 and Second Medical Use Patents
9 de September de 2024
Kasznar Leonardos wins LMG Life Sciences
We are honored to announce that Kasznar Leonardos has won the Firm of the Year: Brazil award at the LMG Life Sciences! … Kasznar Leonardos wins LMG Life Sciences
4 de May de 2023
Kasznar Leonardos attends the BIO International Convention
Our specialists Lívia Figueiredo and Jansen Viana are set to attend the BIO International Convention, which will take place from June 5-8, 2023, … Kasznar Leonardos attends the BIO International Convention